DD102693A5 - - Google Patents

Info

Publication number
DD102693A5
DD102693A5 DD168334A DD16833473A DD102693A5 DD 102693 A5 DD102693 A5 DD 102693A5 DD 168334 A DD168334 A DD 168334A DD 16833473 A DD16833473 A DD 16833473A DD 102693 A5 DD102693 A5 DD 102693A5
Authority
DD
German Democratic Republic
Application number
DD168334A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD102693A5 publication Critical patent/DD102693A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DD168334A 1972-01-22 1973-01-19 DD102693A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722203048 DE2203048A1 (de) 1972-01-22 1972-01-22 Wasserloesliche sterinsulfate

Publications (1)

Publication Number Publication Date
DD102693A5 true DD102693A5 (cg-RX-API-DMAC10.html) 1973-12-20

Family

ID=5833749

Family Applications (1)

Application Number Title Priority Date Filing Date
DD168334A DD102693A5 (cg-RX-API-DMAC10.html) 1972-01-22 1973-01-19

Country Status (17)

Country Link
US (1) US3836527A (cg-RX-API-DMAC10.html)
JP (1) JPS4881847A (cg-RX-API-DMAC10.html)
AT (1) AT323344B (cg-RX-API-DMAC10.html)
AU (1) AU465860B2 (cg-RX-API-DMAC10.html)
BE (1) BE794362A (cg-RX-API-DMAC10.html)
BR (1) BR7300391D0 (cg-RX-API-DMAC10.html)
CH (1) CH578019A5 (cg-RX-API-DMAC10.html)
DD (1) DD102693A5 (cg-RX-API-DMAC10.html)
DE (1) DE2203048A1 (cg-RX-API-DMAC10.html)
DK (1) DK129991B (cg-RX-API-DMAC10.html)
ES (1) ES410828A1 (cg-RX-API-DMAC10.html)
FR (1) FR2181680B1 (cg-RX-API-DMAC10.html)
GB (1) GB1367025A (cg-RX-API-DMAC10.html)
HU (1) HU164290B (cg-RX-API-DMAC10.html)
IL (1) IL41234A (cg-RX-API-DMAC10.html)
NL (1) NL7217831A (cg-RX-API-DMAC10.html)
ZA (1) ZA729168B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021458A (en) * 1974-04-18 1977-05-03 Schering Aktiengesellschaft Process for the preparation of 3-hemisulfate-17α-hydroxy steroids
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
DE19642875B4 (de) * 1996-10-17 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Sterolsulfaten
DE69933016T2 (de) * 1998-03-26 2007-03-29 Phytopharm Plc, Godmanchester Steroidale saponine zur behandlung der alzheimerischen krankheit
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
CA2508913A1 (en) * 2002-12-24 2004-07-15 The University Of British Columbia Angiogenic compounds and uses thereof
ITMI20030822A1 (it) * 2003-04-18 2004-10-19 Erregierre Spa Processo per la preparazione dell'acido ursodesossicolico
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
MX2021011641A (es) 2013-12-24 2023-03-10 Durect Corp Usos de sulfatos de colesterol oxigenados (soc).
HUE059768T2 (hu) 2016-08-02 2022-12-28 Univ Virginia Commonwealth 5-kolesztén-3,25-diol, 3-szulfátot (25HC3S) vagy annak gyógyszerészetileg elfogadható sóját és legalább egy ciklikus oligoszacharidot tartalmazó készítmények

Also Published As

Publication number Publication date
AU465860B2 (en) 1975-10-09
BR7300391D0 (pt) 1973-10-25
IL41234A0 (en) 1973-03-30
FR2181680B1 (cg-RX-API-DMAC10.html) 1975-10-10
BE794362A (fr) 1973-07-23
DE2203048A1 (de) 1973-08-16
GB1367025A (en) 1974-09-18
HU164290B (cg-RX-API-DMAC10.html) 1974-01-28
AU5127873A (en) 1974-07-25
FR2181680A1 (cg-RX-API-DMAC10.html) 1973-12-07
ZA729168B (en) 1973-09-26
DK129991B (da) 1974-12-09
DK129991C (cg-RX-API-DMAC10.html) 1975-05-20
IL41234A (en) 1976-05-31
NL7217831A (cg-RX-API-DMAC10.html) 1973-07-24
CH578019A5 (cg-RX-API-DMAC10.html) 1976-07-30
US3836527A (en) 1974-09-17
ES410828A1 (es) 1976-04-16
JPS4881847A (cg-RX-API-DMAC10.html) 1973-11-01
AT323344B (de) 1975-07-10

Similar Documents

Publication Publication Date Title
JPS5053003A (cg-RX-API-DMAC10.html)
DK129991C (cg-RX-API-DMAC10.html)
CS162796B2 (cg-RX-API-DMAC10.html)
JPS4887437U (cg-RX-API-DMAC10.html)
JPS525970B2 (cg-RX-API-DMAC10.html)
JPS527686Y2 (cg-RX-API-DMAC10.html)
JPS4917609U (cg-RX-API-DMAC10.html)
JPS5543290Y2 (cg-RX-API-DMAC10.html)
SU431477A1 (cg-RX-API-DMAC10.html)
JPS521726B2 (cg-RX-API-DMAC10.html)
JPS48108519U (cg-RX-API-DMAC10.html)
CS159023B1 (cg-RX-API-DMAC10.html)
CS151852B1 (cg-RX-API-DMAC10.html)
CS151860B1 (cg-RX-API-DMAC10.html)
CS153434B2 (cg-RX-API-DMAC10.html)
CS159521B1 (cg-RX-API-DMAC10.html)
CS154550B1 (cg-RX-API-DMAC10.html)
CS155018B1 (cg-RX-API-DMAC10.html)
CS156818B1 (cg-RX-API-DMAC10.html)
CS156937B1 (cg-RX-API-DMAC10.html)
CS159086B1 (cg-RX-API-DMAC10.html)
CS167572B1 (cg-RX-API-DMAC10.html)
CS165031B1 (cg-RX-API-DMAC10.html)
CS163448B1 (cg-RX-API-DMAC10.html)
CS153945B1 (cg-RX-API-DMAC10.html)